I agree that this site is using cookies. You can find further informations here.
X
Rosenblat, Todd
21  results:
Search for persons X
?
1

CLL-542 High Rates of Undetectable Minimal Residual Disease..:

Lipsky, Andrew ; Hill, Brian ; Winter, Allison...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S328 , 2023
Link: https://doi.org/10.1016/..
 
?
2

POSTER: CLL-542 High Rates of Undetectable Minimal Residual..:

Lipsky, Andrew ; Hill, Brian ; Winter, Allison...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S173 , 2023
Link: https://doi.org/10.1016/..
 
?
3

AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-..:

Pammaraju, Naveen ; Kantarjian, Hagop ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S246-S247 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Poster: AML-397 Integrated Safety Analysis of Tagraxofusp, ..:

Pammaraju, Naveen ; Kantarjian, Hagop ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S126 , 2022
Link: https://doi.org/10.1016/..
 
?
5

AML-373: Tagraxofusp, a CD123-Targeted Therapy, in Patients..:

Pemmaraju, Naveen ; Lane, Andrew ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S209-S210 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpe..:

Maslak, Peter G. ; Dao, Tao ; Bernal, Yvette...
Blood Advances.  2 (2018)  3 - p. 224-234 , 2018
Link: https://doi.org/10.1182/..
 
?
7

Targeted Radionuclide Therapy:

, In: Clinical Radiation Oncology,
Jurcic, Joseph Gerard ; Wong, Jeffrey Y.C. ; Knox, Susan J.... - p. 399-418.e14 , 2016
Link: https://doi.org/10.1016/..
 
?
8

A Phase I Trial of a Pharmacodynamically-Conceived Thioguan..:

Lee, Daniel ; Rosenblat, Todd ; Heaney, Mark...
Clinical Lymphoma Myeloma and Leukemia.  16 (2016)  - p. S24 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Contributors:

, In: Clinical Radiation Oncology,
Abrams, Ross A. ; Adelstein, David J. ; Alektiar, Kaled M.... - p. vii-xv , 2016
Link: https://doi.org/10.1016/..
 
?
10

Administration of ATRA to newly diagnosed patients with acu..:

Altman, Jessica K. ; Rademaker, Alfred ; Cull, Elizabeth...
Leukemia Research.  37 (2013)  9 - p. 1004-1009 , 2013
Link: https://doi.org/10.1016/..
 
?
11

Emerging new approaches for the treatment of acute promyelo..:

Park, Jae ; Jurcic, Joseph G. ; Rosenblat, Todd.
Therapeutic Advances in Hematology.  2 (2011)  5 - p. 335-352 , 2011
Link: https://doi.org/10.1177/..
 
?
12

Long-Term Benefits of Tagraxofusp for Patients With Blastic..:

Pemmaraju, Naveen ; Sweet, Kendra L ; Stein, Anthony S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462530/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Treatment of Patients with Acute Myeloid Leukemia with the ..:

Rosenblat, Todd L ; McDevitt, Michael R ; Carrasquillo, Jorge A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106874/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpe..:

Maslak, Peter G ; Dao, Tao ; Bernal, Yvette...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812332/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
15

Phase 2 study of guadecitabine (SGI-110), a novel hypomethy..:

Kantarjian, Hagop M ; Roboz, Gail J ; Kropf, Patricia L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925750/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
1-15